▶ 調査レポート

世界の爪真菌症（爪白癬）薬市場：動向・競争分析
• 英文タイトル：Global Onychomycosis (Tinea Unguium) Drug  Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の爪真菌症（爪白癬）薬市場：動向・競争分析 / Global Onychomycosis (Tinea Unguium) Drug  Industry Research Report, Growth Trends and Competitive Analysis 2019-2025 / QYR9ST12685資料のイメージです。• レポートコード：QYR9ST12685
• 出版社/出版日：QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療
• 販売価格（消費税別）
  Single User￥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License￥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※本調査レポートでは、世界の爪真菌症（爪白癬）薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。爪真菌症（爪白癬）薬の種類別には、経口薬、外用薬に、用途別には、18歳未満、18〜50歳、50歳以上に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・爪真菌症（爪白癬）薬の種類別市場規模：経口薬、外用薬
・爪真菌症（爪白癬）薬の用途別市場規模：18歳未満、18〜50歳、50歳以上
・爪真菌症（爪白癬）薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Johnson and Johnson、GSK、Novartis、Pfizer、Valeant Pharma、Kaken Pharmaceutical、Galderma、Xiuzheng Pharmaceutical、Letai、Qilu Pharmaceutical
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
USA is the largest consumption place, with a consumption market share nearly 33.14% in 2016. Following USA, Europe is the second largest consumption place with the consumption market share of 23.66%.Market competition is intense. Johnson & Johnson, GSK, Novartis, Pfizer, Valeant PharmaKaken Pharmaceutical are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The Onychomycosis (Tinea Unguium) Drug market was valued at 2708.8 Million US$ in 2018 and is projected to reach 3331.8 Million US$ by 2025, at a CAGR of 3.1% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Onychomycosis (Tinea Unguium) Drug.

This study focuses on the production side and consumption side of Onychomycosis (Tinea Unguium) Drug, presents the global Onychomycosis (Tinea Unguium) Drug market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.

In terms of production side, this report researches the Onychomycosis (Tinea Unguium) Drug capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.

In terms of consumption side, this report focuses on the consumption of Onychomycosis (Tinea Unguium) Drug by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.
In 2018, the global Onychomycosis (Tinea Unguium) Drug  market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Onychomycosis (Tinea Unguium) Drug .

This study researches the market size of Onychomycosis (Tinea Unguium) Drug , presents the global Onychomycosis (Tinea Unguium) Drug  sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Onychomycosis (Tinea Unguium) Drug  in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Onychomycosis (Tinea Unguium) Drug  for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
GSK
Novartis
Pfizer
Valeant Pharma
Kaken Pharmaceutical
Galderma
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical

Market Segment by Product Type
Oral Medication
External Medicine

Market Segment by Application
Age under 18
Age 18-50
Age above 50

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Onychomycosis (Tinea Unguium) Drug  status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Onychomycosis (Tinea Unguium) Drug  manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Onychomycosis (Tinea Unguium) Drug  are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Onychomycosis (Tinea Unguium) Drug  Market Size Growth Rate by Type
1.3.2 Oral Medication
1.3.3 External Medicine
1.4 Market Segment by Application
1.4.1 Global Onychomycosis (Tinea Unguium) Drug  Market Share by Application (2019-2025)
1.4.2 Age under 18
1.4.3 Age 18-50
1.4.4 Age above 50
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Onychomycosis (Tinea Unguium) Drug  Market Size
2.1.1 Global Onychomycosis (Tinea Unguium) Drug  Revenue 2014-2025
2.1.2 Global Onychomycosis (Tinea Unguium) Drug  Sales 2014-2025
2.2 Onychomycosis (Tinea Unguium) Drug  Growth Rate by Regions
2.2.1 Global Onychomycosis (Tinea Unguium) Drug  Sales by Regions 2014-2019
2.2.2 Global Onychomycosis (Tinea Unguium) Drug  Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Onychomycosis (Tinea Unguium) Drug  Sales by Manufacturers
3.1.1 Onychomycosis (Tinea Unguium) Drug  Sales by Manufacturers 2014-2019
3.1.2 Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Onychomycosis (Tinea Unguium) Drug  Revenue by Manufacturers (2014-2019)
3.2.2 Onychomycosis (Tinea Unguium) Drug  Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Onychomycosis (Tinea Unguium) Drug  Market Concentration Ratio (CR5 and HHI)
3.3 Onychomycosis (Tinea Unguium) Drug  Price by Manufacturers
3.4 Key Manufacturers Onychomycosis (Tinea Unguium) Drug  Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Onychomycosis (Tinea Unguium) Drug  Market
3.6 Key Manufacturers Onychomycosis (Tinea Unguium) Drug  Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Medication Sales and Revenue (2014-2019)
4.1.2 External Medicine Sales and Revenue (2014-2019)
4.2 Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type
4.3 Global Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Type
4.4 Onychomycosis (Tinea Unguium) Drug  Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Onychomycosis (Tinea Unguium) Drug  Sales by Application

6 North America
6.1 North America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Company
6.2 North America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Type
6.3 North America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Application
6.4 North America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Countries
6.4.1 North America Onychomycosis (Tinea Unguium) Drug  Sales by Countries
6.4.2 North America Onychomycosis (Tinea Unguium) Drug  Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Company
7.2 Europe Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Type
7.3 Europe Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Application
7.4 Europe Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Countries
7.4.1 Europe Onychomycosis (Tinea Unguium) Drug  Sales by Countries
7.4.2 Europe Onychomycosis (Tinea Unguium) Drug  Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Company
8.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Type
8.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Application
8.4 Asia Pacific Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Regions
8.4.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales by Countries
8.4.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug  Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Company
9.2 Central & South America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Type
9.3 Central & South America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Application
9.4 Central & South America Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Countries
9.4.1 Central & South America Onychomycosis (Tinea Unguium) Drug  Sales by Countries
9.4.2 Central & South America Onychomycosis (Tinea Unguium) Drug  Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Type
10.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Application
10.3 Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Breakdown Data by Countries
10.3.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales by Countries
10.3.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.1.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.1.5 Johnson and Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.2.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.3.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.4.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.4.5 Pfizer Recent Development
11.5 Valeant Pharma
11.5.1 Valeant Pharma Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.5.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.5.5 Valeant Pharma Recent Development
11.6 Kaken Pharmaceutical
11.6.1 Kaken Pharmaceutical Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.6.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.6.5 Kaken Pharmaceutical Recent Development
11.7 Galderma
11.7.1 Galderma Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.7.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.7.5 Galderma Recent Development
11.8 Xiuzheng Pharmaceutical
11.8.1 Xiuzheng Pharmaceutical Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.8.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.8.5 Xiuzheng Pharmaceutical Recent Development
11.9 Letai
11.9.1 Letai Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.9.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.9.5 Letai Recent Development
11.10 Qilu Pharmaceutical
11.10.1 Qilu Pharmaceutical Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug 
11.10.4 Onychomycosis (Tinea Unguium) Drug  Product Introduction
11.10.5 Qilu Pharmaceutical Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Onychomycosis (Tinea Unguium) Drug  Sales Channels
12.2.2 Onychomycosis (Tinea Unguium) Drug  Distributors
12.3 Onychomycosis (Tinea Unguium) Drug  Customers

13 Market Forecast
13.1 Global Onychomycosis (Tinea Unguium) Drug  Sales and Revenue Forecast 2019-2025
13.2 Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Type
13.3 Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Application
13.4 Onychomycosis (Tinea Unguium) Drug  Forecast by Regions
13.4.1 Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Regions 2019-2025
13.4.2 Global Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Onychomycosis (Tinea Unguium) Drug  Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Onychomycosis (Tinea Unguium) Drug  Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Onychomycosis (Tinea Unguium) Drug  Product Picture
Table Onychomycosis (Tinea Unguium) Drug  Key Market Segments
Table Major Manufacturers Onychomycosis (Tinea Unguium) Drug  Covered in This Report
Table Global Onychomycosis (Tinea Unguium) Drug  Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Shar by Type 2014-2025
Figure Oral Medication Figures
Table Major Manufacturers of Oral Medication
Figure External Medicine Figures
Table Major Manufacturers of External Medicine
Table Global Onychomycosis (Tinea Unguium) Drug  Market Share by Application 2019-2025 (K MT)
Figure Age under 18 Use Case
Figure Age 18-50 Use Case
Figure Age above 50 Use Case
Figure Onychomycosis (Tinea Unguium) Drug  Report Years Considered
Figure Global Onychomycosis (Tinea Unguium) Drug  Market Size 2014-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales 2014-2019 (K MT)
Table Global Onychomycosis (Tinea Unguium) Drug  Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales by Regions 2014-2019 (K MT)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Regions in 2018
Table Global Onychomycosis (Tinea Unguium) Drug  Revenue by Regions 2014-2019 (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Regions 2014-2019
Figure Global Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Onychomycosis (Tinea Unguium) Drug  Sales by Manufacturers (2014-2019) (K MT)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Share by Manufacturers (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Share by Manufacturers in 2018
Table Onychomycosis (Tinea Unguium) Drug  Revenue by Manufacturers (2014-2019) (Million USD)
Table Onychomycosis (Tinea Unguium) Drug  Revenue Share by Manufacturers (2014-2019)
Figure Onychomycosis (Tinea Unguium) Drug  Value Share by Manufacturers in 2018
Table Global Onychomycosis (Tinea Unguium) Drug  Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug  Price (2014-2019) (USD/MT)
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug  Plants/Factories Distribution
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug  Area Served
Table Date of Key Manufacturers Enter into Onychomycosis (Tinea Unguium) Drug  Market
Table Key Manufacturers Onychomycosis (Tinea Unguium) Drug  Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Oral Medication Sales an目录输出!D Revenue (2014-2019) (K MT) & (Million US$)
Table Global External Medicine Sales an目录输出!D Revenue (2014-2019) (K MT) & (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales by Type (2014-2019) (K MT)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type in 2018
Table Global Onychomycosis (Tinea Unguium) Drug  Revenue by Type (2014-2019) (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug  Revenue Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Type (2014-2019)
Figure Global Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Type in 2018
Table Onychomycosis (Tinea Unguium) Drug  Price by Type 2014-2019 (USD/MT)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales by Application (2014-2019) (K MT)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Share by Application (2014-2019)
Figure Global Sales Onychomycosis (Tinea Unguium) Drug  Market Share by Application (2014-2019)
Figure Global Sales Onychomycosis (Tinea Unguium) Drug  Market Share by Application in 2018
Figure North America Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate 2014-2019 (K MT)
Figure North America Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate 2014-2019 (Million US$)
Table North America Onychomycosis (Tinea Unguium) Drug  Sales by Company (2014-2019) (K MT)
Table North America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Company (2014-2019)
Figure North America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Company in 2018
Table North America Onychomycosis (Tinea Unguium) Drug  Sales by Type (2014-2019) (K MT)
Table North America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type (2014-2019)
Figure North America Onychomycosis (Tinea Unguium) Drug  Market Share by Type in 2018
Table North America Onychomycosis (Tinea Unguium) Drug  Sales by Application (2014-2019) (K MT)
Table North America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Application (2014-2019)
Figure North America Onychomycosis (Tinea Unguium) Drug  Market Share by Application in 2018
Table North America Onychomycosis (Tinea Unguium) Drug  Sales by Countries (2014-2019) (K MT)
Table North America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries (2014-2019)
Figure North America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries in 2018
Table North America Onychomycosis (Tinea Unguium) Drug  Revenue by Countries (2014-2019) (Million US$)
Table North America Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries (2014-2019)
Figure North America Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries in 2018
Figure United States Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Canada Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Europe Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate 2014-2019 (K MT)
Figure Europe Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales by Company (2014-2019) (K MT)
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Company (2014-2019)
Figure Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Company in 2018
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales by Type (2014-2019) (K MT)
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type (2014-2019)
Figure Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type in 2018
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales by Application (2014-2019) (K MT)
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Application (2014-2019)
Figure Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Application in 2018
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales by Countries (2014-2019) (K MT)
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries (2014-2019)
Figure Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries in 2018
Table Europe Onychomycosis (Tinea Unguium) Drug  Revenue by Countries (2014-2019) (Million US$)
Table Europe Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries (2014-2019)
Figure Europe Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries in 2018
Figure Germany Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure France Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure UK Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Italy Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Russia Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales by Regions (2014-2019) (K MT)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Regions in 2018
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales by Type (2014-2019) (K MT)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type (2014-2019)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug  Market Share by Type in 2018
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales by Application (2014-2019) (K MT)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Application (2014-2019)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug  Market Share by Application in 2018
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Regions in 2018
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Regions in 2018
Figure China Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure China Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Japan Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Korea Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure India Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure India Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Australia Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales by Company (2014-2019) (K MT)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Company (2014-2019)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Company in 2018
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales by Type (2014-2019) (K MT)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type (2014-2019)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug  Market Share by Type in 2018
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales by Application (2014-2019) (K MT)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Application (2014-2019)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug  Market Share by Application in 2018
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales by Countries (2014-2019) (K MT)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries (2014-2019)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries in 2018
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries (2014-2019)
Figure Central & South America Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries in 2018
Figure Brazil Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (K MT)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales by Type (2014-2019) (K MT)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Type in 2018
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales by Application (2014-2019) (K MT)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Application in 2018
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Market Share by Countries in 2018
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Revenue Market Share by Countries in 2018
Figure GCC Countries Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (K MT)
Figure Egypt Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (K MT)
Figure South Africa Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Onychomycosis (Tinea Unguium) Drug  Revenue Growth Rate (2014-2019) (K MT)
Table Johnson and Johnson Company Details
Table Johnson and Johnson Description and Business Overview
Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Johnson and Johnson Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table GSK Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table GSK Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Novartis Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Pfizer Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Pfizer Recent Development
Table Valeant Pharma Company Details
Table Valeant Pharma Description and Business Overview
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Valeant Pharma Recent Development
Table Kaken Pharmaceutical Company Details
Table Kaken Pharmaceutical Description and Business Overview
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Kaken Pharmaceutical Recent Development
Table Galderma Company Details
Table Galderma Description and Business Overview
Table Galderma Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Galderma Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Galderma Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Galderma Recent Development
Table Xiuzheng Pharmaceutical Company Details
Table Xiuzheng Pharmaceutical Description and Business Overview
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Xiuzheng Pharmaceutical Recent Development
Table Letai Company Details
Table Letai Description and Business Overview
Table Letai Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Letai Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Letai Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Letai Recent Development
Table Qilu Pharmaceutical Company Details
Table Qilu Pharmaceutical Description and Business Overview
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Growth Rate (2014-2019)
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Market Share in Global Market
Table Qilu Pharmaceutical Recent Development
Figure Onychomycosis (Tinea Unguium) Drug  Value Chain
Table Onychomycosis (Tinea Unguium) Drug  Distributors List
Table Onychomycosis (Tinea Unguium) Drug  Customers List
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Global Onychomycosis (Tinea Unguium) Drug  Revenue Forecast 2019-2025 (Million US$)
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Type 2019-2025 (K MT)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Type 2019-2025 (K MT)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Type 2019-2025
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Application 2019-2025 (K MT)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Application 2019-2025 (K MT)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Application 2019-2025
Table Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Regions 2019-2025
Table Global Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Onychomycosis (Tinea Unguium) Drug  Revenue Market Share Forecast by Regions 2019-2025
Table North America Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Countries 2019-2025 (K MT)
Table North America Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Countries 2019-2025
Table North America Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Onychomycosis (Tinea Unguium) Drug  Revenue Market Share Forecast by Countries 2019-2025
Figure United States Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Canada Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Mexico Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Countries 2019-2025 (K MT)
Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Countries 2019-2025
Table Europe Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Onychomycosis (Tinea Unguium) Drug  Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure France Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure UK Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Italy Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Russia Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Regions 2019-2025 (K MT)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Onychomycosis (Tinea Unguium) Drug  Revenue Market Share Forecast by Regions 2019-2025
Figure China Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Japan Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure South Korea Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure India Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Australia Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Indonesia Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Thailand Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Malaysia Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Philippines Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Vietnam Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Countries 2019-2025 (K MT)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Onychomycosis (Tinea Unguium) Drug  Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Forecast by Regions 2019-2025 (K MT)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure GCC Countries Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure Egypt Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Figure South Africa Onychomycosis (Tinea Unguium) Drug  Sales Forecast 2019-2025 (K MT)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の爪真菌症（爪白癬）薬市場：動向・競争分析
    Global Onychomycosis (Tinea Unguium) Drug Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9ST03361 2019年9月2日 116Pages
    ※本調査レポートでは、世界の爪真菌症（爪白癬）薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。爪真菌症（爪白癬）薬の種類別には、経口薬、外用薬に、用途別には、18歳未満、18〜50歳、50歳以上に、地域別には、...
  • 皮膚糸状菌真菌症治療の世界市場：市場規模・現状・予測
    Global Dermatophytic Onychomycosis Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST04152 2019年9月2日 97Pages
    ※当調査レポートでは、皮膚糸状菌真菌症治療の世界市場について調査・分析し、皮膚糸状菌真菌症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（全身療法、局所療法、その他）、用途別（病院、皮膚科、その...
  • レブリミド薬の世界市場：インサイト・予測
    Global Revlimid Drug Market Insights, Forecast to 2025
    QYR9ST02645 2019年9月2日 116Pages
    ※本調査レポートでは、世界のレブリミド薬市場について調査・分析し、以下の構成でお届け致します。レブリミド薬の種類別には、10mg、25mg、その他に、用途別には、病院、薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセ...
  • コセンティクス薬の世界市場：インサイト・予測
    Global Cosentyx- Drug Market Insights, Forecast to 2025
    QYR9ST00870 2019年9月2日 119Pages
    ※本調査レポートでは、世界のコセンティクス薬市場について調査・分析し、以下の構成でお届け致します。コセンティクス薬の種類別には、センソレディーペン、プレフィルドシリンジに、用途別には、病院、医薬品店に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリ...
  • アフィニトール薬の世界市場：インサイト・予測
    Global Afinitor Drug Market Insights, Forecast to 2025
    QYR9ST00769 2019年9月2日 114Pages
    ※本調査レポートでは、世界のアフィニトール薬市場について調査・分析し、以下の構成でお届け致します。アフィニトール薬の種類別には、2.5mg、5mg、7mg、10mgに、用途別には、病院、ドラッグストア、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中...
  • レナリドミド薬の世界市場：インサイト・予測
    Global Lenalidomide Drug Market Insights, Forecast to 2025
    QYR9ST01044 2019年9月2日 119Pages
    ※本調査レポートでは、世界のレナリドミド薬市場について調査・分析し、以下の構成でお届け致します。レナリドミド薬の種類別には、5 mgカプセル、10 mgカプセル、15 mgカプセル、25 mgカプセルに、用途別には、多発性骨髄腫（MM）、骨髄異形成症候群（MDS）、その他に、地域別には、北米、アメリ...
  • 世界のCOPD・喘息治療薬市場：動向・競争分析
    Global COPD and Asthma Drug Devices Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9ST01831 2019年9月2日 113Pages
    ※本調査レポートでは、世界のCOPD・喘息治療薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。COPD・喘息治療薬の種類別には、COPDと喘息吸入器、COPDと喘息ネブライザに、用途別には、病院、診療所、その他...
  • 予防喘息薬の世界市場：インサイト・予測
    Global Preventive Asthma Drug Market Insights, Forecast to 2025
    QYR9ST03007 2019年9月2日 118Pages
    ※本調査レポートでは、世界の予防喘息薬市場について調査・分析し、以下の構成でお届け致します。予防喘息薬の種類別には、ソマトスタチンアナログ、標的療法、化学療法に、用途別には、病院、診療所、腫瘍センターに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフ...
  • 糖尿病黄斑浮腫薬の世界市場：インサイト・予測
    Global Diabetic Macular Edema Drug Market Insights, Forecast to 2025
    QYR9ST02854 2019年9月2日 112Pages
    ※本調査レポートでは、世界の糖尿病黄斑浮腫薬市場について調査・分析し、以下の構成でお届け致します。糖尿病黄斑浮腫薬の種類別には、硝子体内注射、硝子体内インプラントに、用途別には、抗VEGF、コルチコステロイド、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中...
  • 喘息及びCOPD薬の世界市場：インサイト・予測
    Global Asthma and COPD Drug Market Insights, Forecast to 2025
    QYR9ST00048 2019年9月2日 111Pages
    ※本調査レポートでは、世界の喘息及びCOPD薬市場について調査・分析し、以下の構成でお届け致します。喘息及びCOPD薬の種類別には、気管支拡張薬、抗炎症薬、モノクローナル抗体、併用薬に、用途別には、喘息、COPDに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米...
  • 世界の爪真菌症（爪白癬）薬市場：動向・競争分析世界の爪真菌症（爪白癬）薬市場：動向・競争分析 Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease. USA is the largest consumption place, with a consumption market sha…
  • 皮膚糸状菌真菌症治療の世界市場：市場規模・現状・予測皮膚糸状菌真菌症治療の世界市場：市場規模・現状・予測 Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails.Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment oft…
  • 経口制御放出ドラッグデリバリーテクノロジーの世界市場：インサイト・予測経口制御放出ドラッグデリバリーテクノロジーの世界市場：インサイト・予測 The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes.…
  • 世界の経口抗糖尿病薬市場：専門的調査世界の経口抗糖尿病薬市場：専門的調査 Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are of…
  • 世界の口腔液薬物検査システム市場：専門的調査世界の口腔液薬物検査システム市場：専門的調査 Oral fluid testing analyzes a saliva sample for parent drugs and their metabolites. An absorbent collection device is placed in the mouth and the saliva collected is screened for drugs of abuse. Samples are checked to verify the saliva is human and undiluted. The global Oral Fluid Drug Test System m…